Zanco Journal of Medical Sciences
Skip Navigation Links
Available Issues
Editorial Board
Information for Authors
Review Process
Links and Contacts
  Zanko J Med Sci:  Aug. 2017; 21 (2): 1743-1750

Association of C-reactive protein positivity among groups of patients with knee osteoarthritis in Erbil

Helen Ahmed Pirdawood*, Niaz Jawad**


* Erbil Directorate of Health, Erbil, Iraq.

** Department of Internal Medicine, College of Medicine, Hawler Medical University, Erbil, Iraq.


Background and objective: Osteoarthritis is the most common joint disease and a leading cause of disability. Increased circulating levels of C-reactive protein have been associated with prevalent knee osteoarthritis. This study aimed to assess the association between C- reactive protein positivity in patients with knee osteoarthritis in Erbil

Methods: Data from100 participants in this case-control study were enrolled from May 1st to December 1st, 2015 in Rizgary Teaching Hospital in Erbil city. Data were divided into two groups. The cases included 50 patients (17 male and 33 female) with a mean age of 58.9 ±3.8 years and diagnosed with primary knee osteoarthritis of one or both knee joints. Controls included 50 persons (17 male and 33 female) with a mean age of 58.1 ±3.9 years without knee osteoarthritis and matched for age, sex, and body mass index. C-reactive protein qualitatively measured. Patients were radiologically assessed by Kellgren and Lawrence grading scale (grade 0-4).

Results: C-reactive protein was positive in 41 out of 50 (82%) of knee osteoarthritis patients compared to 3 out of 50 (6%) of healthy controls (P = 0.001). C- reactive protein positivity among knee osteoarthritis patients were significantly associated with body mass index, positive family history of knee osteoarthritis, duration of diseases, and Kellgren and Lawrence grade (P <0.05). No significant association was found with sex, site of knee joint involvement, and knee pain severity (P >0.05).

Conclusion: C-reactive protein positivity was significantly associated with knee osteoarthritis compared to healthy controls. Furthermore, body mass index, positive family history of knee osteoarthritis, early osteoarthritis, and Kellgren and Lawrence grade II, were significantly associated with positive C-reactive protein in knee osteoarthritis.

Keywords: Osteoarthritis; Knee osteoarthritis; C-reactive protein; Kellgren and Lawrence grade.


1. Amanda EN, Joanne MJ, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, et al. Osteoarthritis: epidemiology and classification. In: Hochberg MC, editors. Rheumatology.5th ed. Philadelphia, USA: Mosby, Elsevier; 2011. P. 1706-17.

2. Lane NE, Schnitzer TJ. Osteoarthritis, In: Lee Goldman, Andrew I. Schafer: Goldman ̓s Cecil Medicine. 24th ed. Philadelphia USA: Elsevier; 2012. P. 1672-6.

3. Brooks P. Inflammation as an important feature of osteoarthritis. Bull World Health Organ 2003; 81: 689- 90.

4. Xu L, Zhu GB, Wang L, Wang D, Jiang XR. Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis. J Investig Med 2012; 60:583–6.

5. Pelletier JP, Martel-Pelletier J. The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: From molecule to man. Arthritis Res 2002; 4: 13-9.

6. Bejon P, Byren I, Atkins BL, Scarborough M, Woodhouse A, Lardy-Smith P, et al. Serial measurement of the C-reactive protein is a poor predictor of treatment outcome in prosthetic joint infection. J Antimicrob Chemother 2011; 66(3): 1590.

7. Dolzani P, Assirelli E, Pulsatelli L, Addimanda O, Mancarella L, Peri G, et al. Systemic inflammation and antibodies to citrullinated peptides in hand osteoarthritis. Clin Exp Rheumatol 2011; 29(9): 1006.

8. Rhodes B, Furnrohr BG, Vyse TJ. C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol 2011; 7(9):282.

9. Karsdal MA, Henriksen K, Leeming DJ, Woodworth T, Vassiliadis E, Bay-Jensen AC. Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers e are they the cause or the consequence of the disease? Clin Biochem 2010; 804: 43:793.

10. Ehrlich GE. The rise of osteoarthritis, Bull World Health Organ 2003; 81:630-1.

11. Scanzello C, Goldring S. The role of synovitis in osteoarthritis pathogenesis. Bone 2012; 51:    249–57.

12. Sharif M, Shepstone L, Elson CJ, Dieppe PA, Kirwan JR. Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis 2000; 59(4): 71.

13. Hanna FS, Bell RJ, Cicuttini FM, Davison SL, Wluka AE, Davis SR. High sensitivity C-reactive protein is associated with lower tibial cartilage volume but not lower patella cartilage volume in healthy women at mid-life. Arthritis Res Ther 2008; 10: R27.

14. Altman R, Asch E, Bloch G. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum1986; 29:1039–49.

15. Turk DC, Melzack R. Handbook of pain assessment. New York: Guliford Press; 2001.

16. Benito MJ, Veale DJ, FitzGeraldO, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005; 64: 1263–7.

17. Kellgren HJ, Lawrence SJ. Radiological assessment of osteoarthritis. Ann Rheum Dis 1967; 16: 494–501.

18. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011; 23(8): 471.

19. Pierre, Marie Curie M. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013; 21(1).

20. Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage 2002; 10 (8):595-601.

21. Smith JW, Martins TB, Gopez E, Johnson T, Hill HR, Rosenberg TD. Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes. Ther Adv Musculoskelet Dis 2012; 4(5): 315– 25.

22. Pearle AD, Scanzello CR, George S, Mandl LA, SculcoT P ,Crow MK, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007; 15: 516- 23.

23. Legendre F, Dudhia J, Pujol JP, Bogdanowicz P. JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes, Association with a down- regulation of SOX9 expression. J Biol Chem 2003; 278(5): 2903-12.

24. Sturmer T, Brenner H, Koenig W, Gunther KP. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 2004; 63: 200–5.

25. Stannus O, Jones G, Cicuttini F, Parameswaran V, Quinn , Burgess, et al. Circulating levels of IL-6 and TNF-a are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage 2010; 18: 1441- 7.

26. Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997; 40:723-7.

27. Virginia B K, Thomas VS, Gheorghe L, Jordan B R, Anca DD, Joanne M J. Interpretation of Serum C-Reactive Protein (CRP) Levels for Cardiovascular Disease Risk is Complicated by Race, Pulmonary Disease, Body Mass Index, Gender, and Osteoarthritis. Osteoarthritis Cartilage 2007; 8: 966– 71.

28. Engström G, Gerhardsson de Verdier M, Rollof , Nilsson P M, Lohmander LS. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis, a population-based cohort study. Osteoarthritis Cartilage 2009; 17: 168- 73.

29. Vonk LA, Kragten AH, Dhert WJ, Saris DB, Creemers LB. Overexpression of hsa-miR- 148a promotes cartilage production and inhibits cartilage degradation by osteoarthritic chondrocytes. Osteoarthritis Cartilage 2013; 21(1):145-53.

30. Wang X, Hunter D, Xu J, Ding C. Metabolic triggered inflammation in osteoarthritis. Osteoarthritis Cartilage 2015; 23: 22- 30.

31. Miller GD, Nicklas BJ, Loeser RF. Inflammatory biomarkers and physical function in older, obese adults with knee pain and self-reported osteoarthritis after intensive weight-loss therapy. J Am Geriatr Soc 2008; 56(4): 644- 61.

32. Marta I, Fernando E, Fabio MA, Lucy VB, Tania RT, Janini Ch, et al. Serum Levels of Pro-inflammatory Cytokines in Painful Knee Osteoarthritis and Sensitization. International Journal of Inflammation 2015; 8.

33. Nielsen LA, Thomas NE, Line LE, Kristian KP, Nielsen TG, Hans CH, et al. Association Between Experimental Pain Biomarkers and Serologic Markers in Patients With Different Degrees of Painful Knee Osteoarthritis. Arthritis Rheumatol 2014; 66: 3317– 26.

34. Saxne T, Lindell M, Mansson B, Petersson IF, Heinegard D. Inflammation is a feature of the disease process in early knee joint osteoarthritis. Rheumatology 2003; 42: 903–4.

35. Yun ZH, Juwu CH, Guohui Y. Serum and Synovial Fluid Levels of CCL18 are correlated with Radiographic Grading of Knee Osteoarthritis. Med Sci Monit 2015; 21: 840-4.

36. HanadaM, Takahashi M, Furuhashi H, Koyama H, Matsuyama Y. Elevated erythrocyte sedimentation rate and high-sensitivity C-reactive protein in osteoarthritis of the knee: relationship with clinical findings and radiographic severity. Ann Clin Biochem 2015; 51: 11.